Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin dose comparison in COPD with elevated CRP
ACTRN12615000491561Phase 4Not yet recruiting
- Sponsor
- Associate Professor Robert Young
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of simvastatin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Associate Professor Robert Young. Primary endpoint: Change in serum C-reactive protein at Week 12. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
simvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12615000491561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000491561.